ArticleBritish journal of pharmacology2009

Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension.

I Morecroft et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.